DK2830662T3 - Fremgangsmåder til behandlng af hårtabsforstyrrelser - Google Patents

Fremgangsmåder til behandlng af hårtabsforstyrrelser Download PDF

Info

Publication number
DK2830662T3
DK2830662T3 DK13769804.9T DK13769804T DK2830662T3 DK 2830662 T3 DK2830662 T3 DK 2830662T3 DK 13769804 T DK13769804 T DK 13769804T DK 2830662 T3 DK2830662 T3 DK 2830662T3
Authority
DK
Denmark
Prior art keywords
treatment
methods
hair loss
loss disorders
disorders
Prior art date
Application number
DK13769804.9T
Other languages
English (en)
Inventor
Angela M Christiano
Raphael Clynes
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of DK2830662T3 publication Critical patent/DK2830662T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
DK13769804.9T 2012-03-29 2013-03-29 Fremgangsmåder til behandlng af hårtabsforstyrrelser DK2830662T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261617225P 2012-03-29 2012-03-29
US201261645499P 2012-05-10 2012-05-10
PCT/US2013/034688 WO2013149194A1 (en) 2012-03-29 2013-03-29 Methods for treating hair loss disorders

Publications (1)

Publication Number Publication Date
DK2830662T3 true DK2830662T3 (da) 2019-01-02

Family

ID=49261311

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13769804.9T DK2830662T3 (da) 2012-03-29 2013-03-29 Fremgangsmåder til behandlng af hårtabsforstyrrelser

Country Status (12)

Country Link
EP (2) EP2830662B1 (da)
JP (2) JP6212107B2 (da)
KR (1) KR102135601B1 (da)
CN (1) CN104334191A (da)
DK (1) DK2830662T3 (da)
ES (1) ES2694681T3 (da)
HR (1) HRP20181976T1 (da)
HU (1) HUE040127T2 (da)
PL (1) PL2830662T3 (da)
PT (1) PT2830662T (da)
SI (1) SI2830662T1 (da)
WO (1) WO2013149194A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2985185A1 (en) * 2015-05-07 2016-11-10 The Trustees Of Columbia University In The City Of New York Methods and compositions for promoting hair growth
CN104789689B (zh) * 2015-05-13 2018-10-02 北京泱深生物信息技术有限公司 作为肺腺癌诊治靶标的clec9a基因
JP6767491B2 (ja) 2015-09-25 2020-10-14 ディザル（ジァンスー）ファーマシューティカル・カンパニー・リミテッド Ｊａｋを阻害するための化合物及び方法
KR20170101724A (ko) * 2016-02-29 2017-09-06 양지화학 주식회사 야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민의 용도
CN105695617A (zh) * 2016-04-22 2016-06-22 王冬国 乳头状癌的肿瘤标志物及其应用
ES2988629T3 (es) 2016-05-04 2024-11-21 Sun Pharmaceutical Ind Inc Tratamiento de trastornos de pérdida de cabello con inhibidores de JAK deuterados
KR20230110373A (ko) * 2016-06-14 2023-07-21 리전츠 오브 더 유니버스티 오브 미네소타 질환을 치료하기 위한 유전적으로 변형된 세포, 조직,및 장기
KR101657082B1 (ko) * 2016-08-08 2016-09-13 에스씨엠생명과학 주식회사 CXCL1(chemokine (C-X-C motif) ligand 1) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물
AU2017358703A1 (en) * 2016-11-10 2019-05-09 Galapagos Nv Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases
AU2018312349A1 (en) 2017-08-01 2020-02-06 Theravance Biopharma R&D Ip, Llc Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors
US20190142722A1 (en) 2017-11-10 2019-05-16 The Trustees Of Columbia University In The City Of New York Methods and compositions for promoting or inducing hair growth
AU2019282155A1 (en) 2018-06-04 2021-01-07 Lars BRICHTA Topical compositions for stimulating hair growth
CN113498352A (zh) 2019-01-23 2021-10-12 施万生物制药研发Ip有限责任公司 作为jak抑制剂的咪唑并[1,5-a]吡啶、1,2,4-三唑并[4,3-a]吡啶和咪唑并[1,5-a]吡嗪
CN113853443A (zh) * 2019-03-08 2021-12-28 株式会社Neogentc 用于预测淋巴细胞的肿瘤反应性的标志物及其用途
CN111041095B (zh) * 2019-07-11 2021-11-30 江苏医药职业学院 检测8号染色体开放阅读框73表达水平的试剂的应用和试剂盒
KR102187371B1 (ko) * 2019-08-02 2020-12-04 연세대학교 산학협력단 FoxQ1 유전자가 과발현된 지방유래 줄기세포 및 이의 용도
US20220401447A1 (en) * 2019-11-08 2022-12-22 Cage Bio, Inc. Topical delivery of tofacitinib using ionic liquid
US11697648B2 (en) 2019-11-26 2023-07-11 Theravance Biopharma R&D Ip, Llc Fused pyrimidine pyridinone compounds as JAK inhibitors
US12441707B2 (en) 2019-12-30 2025-10-14 Tyra Biosciences, Inc. Indazole compounds
CA3182478A1 (en) * 2020-05-12 2021-11-18 Chemistry Rx Compositions for treating hair loss
FR3111917B1 (fr) * 2020-06-30 2025-04-11 Oreal Signature moléculaire d’un état alopécique commun, associée aux jonctions cellulaires
CA3216017A1 (en) * 2021-04-22 2022-10-27 Shengjian Huang Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereof
CA3228505A1 (en) 2021-08-11 2023-02-16 Sun Pharmaceutical Industries, Inc. Treatment of hair loss disorders with deuterated jak inhibitors
CN116262136A (zh) * 2021-12-13 2023-06-16 复旦大学附属华山医院 以脯氨酰羟化酶为靶点治疗脱发疾病的药物
CN118786125A (zh) * 2022-03-18 2024-10-15 四川科伦博泰生物医药股份有限公司 氮杂环丁烷衍生物的用途及治疗方法
CN114870016B (zh) * 2022-04-21 2023-05-26 上海博悦生物科技有限公司 一种jak抑制剂的微乳泡沫剂及其应用
CN115137832B (zh) * 2022-07-07 2023-11-17 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种jak抑制剂的用途及其抗毛霉感染实验方法
FR3143040A1 (fr) * 2022-12-12 2024-06-14 L'oreal Méthode de pronostic et/ou de diagnostic d’une perte de densité capillaire

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4921475A (en) 1983-08-18 1990-05-01 Drug Delivery Systems Inc. Transdermal drug patch with microtubes
US5087240A (en) 1983-08-18 1992-02-11 Drug Delivery Systems Inc. Transdermal drug patch with conductive fibers
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5163899A (en) 1987-03-20 1992-11-17 Drug Delivery Systems Inc. Transdermal drug delivery system
US5312325A (en) 1987-05-28 1994-05-17 Drug Delivery Systems Inc Pulsating transdermal drug delivery system
US5080891A (en) 1987-08-03 1992-01-14 Ddi Pharmaceuticals, Inc. Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols
US5879680A (en) 1987-12-23 1999-03-09 The United States Of America As Represented By The Department Of Health And Human Services Cloned DNA for synthesizing unique glucocerebrosidase
GB8804164D0 (en) 1988-02-23 1988-03-23 Tucker J M Bandage for administering physiologically active compound
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5008110A (en) 1988-11-10 1991-04-16 The Procter & Gamble Company Storage-stable transdermal patch
US5088977A (en) 1988-12-21 1992-02-18 Drug Delivery Systems Inc. Electrical transdermal drug applicator with counteractor and method of drug delivery
US6451600B1 (en) 1989-12-22 2002-09-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
US5236838A (en) 1988-12-23 1993-08-17 Genzyme Corporation Enzymatically active recombinant glucocerebrosidase
US5096815A (en) 1989-01-06 1992-03-17 Protein Engineering Corporation Generation and selection of novel dna-binding proteins and polypeptides
US5198346A (en) 1989-01-06 1993-03-30 Protein Engineering Corp. Generation and selection of novel DNA-binding proteins and polypeptides
US5179023A (en) 1989-03-24 1993-01-12 Research Corporation Technologies, Inc. Recombinant α-galactosidase a therapy for Fabry disease
US5328470A (en) 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
AU638762B2 (en) 1989-10-05 1993-07-08 Optein Inc Cell-free synthesis and isolation of novel genes and polypeptides
DK0431519T3 (da) 1989-12-04 1994-07-04 Searle & Co System til transdermal indgivelse af albuterol
US5747334A (en) 1990-02-15 1998-05-05 The University Of North Carolina At Chapel Hill Random peptide library
US5401650A (en) 1990-10-24 1995-03-28 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-galactosidase A
CA2108144A1 (en) 1991-03-06 1992-09-07 Jack A. Roth Methods and compositions for the selective inhibition of gene expression
US5747469A (en) 1991-03-06 1998-05-05 Board Of Regents, The University Of Texas System Methods and compositions comprising DNA damaging agents and p53
US6410010B1 (en) 1992-10-13 2002-06-25 Board Of Regents, The University Of Texas System Recombinant P53 adenovirus compositions
US5352456A (en) 1991-10-10 1994-10-04 Cygnus Therapeutic Systems Device for administering drug transdermally which provides an initial pulse of drug
US5252479A (en) 1991-11-08 1993-10-12 Research Corporation Technologies, Inc. Safe vector for gene therapy
DE69228827T2 (de) 1991-12-18 1999-10-21 Minnesota Mining And Mfg. Co., Saint Paul Mehrschichtige sperrstrukturen
ATE132381T1 (de) 1992-01-29 1996-01-15 Voelkl Franz Ski Ballspielschläger, insbesondere tennisschläger
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
AU704183B2 (en) 1994-01-05 1999-04-15 Arqule, Inc. Systematic modular production of aminimide- and oxazolone-based molecules having selected properties
US5705625A (en) * 1994-12-15 1998-01-06 The Johns Hopkins University School Of Medicine Nucleic Acid Encoding novel protein tyrosine kinase
US5712171A (en) 1995-01-20 1998-01-27 Arqule, Inc. Method of generating a plurality of chemical compounds in a spatially arranged array
ES2264145T3 (es) 1995-11-30 2006-12-16 The Board Of Regents, The University Of Texas System Metodos y composiciones para el tratamiento de cancer.
US6458574B1 (en) 1996-09-12 2002-10-01 Transkaryotic Therapies, Inc. Treatment of a α-galactosidase a deficiency
US6083725A (en) 1996-09-13 2000-07-04 Transkaryotic Therapies, Inc. Tranfected human cells expressing human α-galactosidase A protein
GB9623833D0 (en) 1996-11-16 1997-01-08 Zeneca Ltd Chemical compound
US7419661B2 (en) 1997-04-30 2008-09-02 The Centre Of Excellence For Life Sciences Limited Dermal sheath tissue in wound healing
AR013269A1 (es) 1997-08-04 2000-12-13 Scras Producto que contiene por lo menos un rna de doble filamento combinado con por lo menos un agente anti-viral, para la utilizacion terapeutica en eltratamiento de una enfermedad viral, en especial de la hepatitis viral
US6210666B1 (en) 1997-10-21 2001-04-03 Orphan Medical, Inc. Truncated α-galactosidase A to treat fabry disease
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO2000000202A1 (en) * 1998-06-30 2000-01-06 Parker Hughes Institute Method for inhibiting c-jun expression using jak-3 inhibitors
GB9827152D0 (en) 1998-07-03 1999-02-03 Devgen Nv Characterisation of gene function using double stranded rna inhibition
CA2361201A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
MXPA01008142A (es) * 1999-02-10 2003-07-21 Welfide Corp Compuestos de amida, y uso medicinal de los mismos.
HK1047109A1 (zh) 1999-10-15 2003-02-07 University Of Massachusetts 作为指定基因干预工具的rna干预轨迹基因
GB9925964D0 (en) 1999-11-03 1999-12-29 Jahoda Colin A B Hair transplantation
GB9927444D0 (en) 1999-11-19 2000-01-19 Cancer Res Campaign Tech Inhibiting gene expression
US6188045B1 (en) 2000-04-03 2001-02-13 Alto-Shaam, Inc. Combination oven with three-stage water atomizer
IES20010386A2 (en) 2000-04-20 2001-11-14 Bernard Mcnamara A swimming pool assembly
US20020173478A1 (en) 2000-11-14 2002-11-21 The Trustees Of The University Of Pennsylvania Post-transcriptional gene silencing by RNAi in mammalian cells
US7294504B1 (en) 2001-12-27 2007-11-13 Allele Biotechnology & Pharmaceuticals, Inc. Methods and compositions for DNA mediated gene silencing
JP2005528443A (ja) * 2002-05-30 2005-09-22 バーテックス　ファーマシューティカルズ　インコーポレイテッド Ｊａｋキナーゼおよびｃｄｋ２プロテインキナーゼのインヒビター
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
DK1563061T3 (da) 2002-11-14 2012-10-01 Aderans Res Inst Inc Dyrkning af hårinducerende celler
US7884189B2 (en) 2003-01-10 2011-02-08 The Trustees Of Columbia University In The City Of New York Carboxyltransferase domain of acetyl-CoA carboxylase
AU2005237254B2 (en) * 2004-05-03 2010-02-04 Novartis Ag Combinations comprising a S1P receptor agonist and a JAK3 kinase inhibitor
AU2006242154B2 (en) 2005-05-02 2011-11-03 Cold Spring Harbor Laboratory Composition and methods for cancer diagnosis utilizing the mir 17-92 cluster
US20070041905A1 (en) * 2005-08-19 2007-02-22 Hoffman Rebecca S Method of treating depression using a TNF-alpha antibody
CN101563097A (zh) 2005-11-14 2009-10-21 企业合伙人风险资本公司 用于组织损伤的干细胞生长因子疗法
DE602006019916D1 (de) 2005-12-12 2011-03-10 Canji Inc Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase
UA95940C2 (uk) * 2006-01-17 2011-09-26 Вертекс Фармасьютикалс Інкорпорейтед Азаіндоли як інгібітори кіназ януса
BRPI0708347A2 (pt) * 2006-02-28 2011-05-24 Cytopia Res Pty Ltd inibição jak2 como um tratamento da hipertensão arterial pulmonar
US9109204B2 (en) 2006-02-28 2015-08-18 The Trustees Of Columbia University In The City Of New York Methods for compact aggregation of dermal cells
GB0605691D0 (en) * 2006-03-21 2006-05-03 Novartis Ag Organic Compounds
US7704533B2 (en) * 2006-12-13 2010-04-27 J&J Consumer Companies, Inc. Compositions and methods of inducing hair growth utilizing Continus coggygria
EP2274288A2 (en) * 2008-04-24 2011-01-19 Incyte Corporation Macrocyclic compounds and their use as kinase inhibitors
WO2010093808A1 (en) * 2009-02-11 2010-08-19 Reaction Biology Corp. Selective kinase inhibitors
WO2012061537A2 (en) * 2010-11-02 2012-05-10 The Trustees Of Columbia University In The City Of New York Methods for treating hair loss disorders

Also Published As

Publication number Publication date
EP2830662B1 (en) 2018-08-29
CN104334191A (zh) 2015-02-04
JP2015515470A (ja) 2015-05-28
EP2830662A4 (en) 2015-09-09
HRP20181976T1 (hr) 2019-01-25
EP3459565A1 (en) 2019-03-27
PL2830662T3 (pl) 2019-02-28
KR20140148459A (ko) 2014-12-31
PT2830662T (pt) 2018-11-29
HUE040127T2 (hu) 2019-02-28
JP2018027959A (ja) 2018-02-22
WO2013149194A1 (en) 2013-10-03
KR102135601B1 (ko) 2020-07-20
ES2694681T3 (es) 2018-12-26
EP2830662A1 (en) 2015-02-04
JP6527565B2 (ja) 2019-06-05
JP6212107B2 (ja) 2017-10-11
SI2830662T1 (sl) 2019-01-31

Similar Documents

Publication Publication Date Title
DK2830662T3 (da) Fremgangsmåder til behandlng af hårtabsforstyrrelser
DK2635299T3 (da) Fremgangsmåder til behandling af hårtabsforstyrrelser
LT2885010T (lt) Tautopatijos gydymo būdai
DK2983787T3 (da) Fremgangsmåde til behandling af posttraumatisk stresssygdom
DK2968208T3 (da) Behandling af kataplexi
DK2906696T4 (da) Fremgangsmåder til modulering af c9orf72-ekspression
DK2846809T3 (da) Behandling af myelosuppression
DK2897620T3 (da) Fremgangsmåde til behandling af cancer
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
DK2895156T3 (da) Fremgangsmåde til fremstilling af terapeutiske nanopartikler
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
DK3329884T3 (da) Implanterbar indretning til behandling af glaukom
DK3725778T4 (da) Formuleringer af enzalutamid
DK2701733T3 (da) Forbindelser til behandling af neuropsykiatriske forstyrrelser
SI2707029T1 (sl) Metode zdravljenja ali preprečevanja s holesterolom povezanih motenj
DK2981255T3 (da) Terapeutiske anvendelser af empagliflozin
DK3626270T3 (da) Behandling af kardiovaskulære sygdomme
DK3054976T3 (da) Anvendelse af semaphorin-4d-bindende molekyler til behandling af aterosklerose
DK2747763T3 (da) (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser
DK2961378T3 (da) Fremgangsmåder til behandlingen af mitochondrisk sygdom
LT3007726T (lt) Tautopatijos gydymo būdai
DK2897611T3 (da) Fremgangsmåder til behandling af hepatitis c
DK2961426T3 (da) Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g
PL2776055T3 (pl) Sposoby leczenia zaburzeń żołądkowo-jelitowych
BR112013023142A2 (pt) método de tratamento de cabelos